Topline Results: Phase 3 Energize Study of Pyrukynd in Thalassemia slide image

Topline Results: Phase 3 Energize Study of Pyrukynd in Thalassemia

agios Data Highlights from Phase 3 ENERGIZE Study Jeremie Estepp, M.D. Medical Director at Agios
View entire presentation